RT Conference Proceedings
T1 NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
A1 Rodriguez-Abreu, D.
A1 Campillo, J.
A1 Grau, F.
A1 Carcereny, E.
A1 Bernabe, R.
A1 Garcia, Y.
A1 Artal Cortes, A.
A1 Gonzalez Cao, M.
A1 Juan, O.
A1 Garicano, F.
A1 Gil-Bazo, I.
A1 Blanco, R.
A1 Guillot, M.
A1 Provencio, M.
A1 Majem, M.
K1 real world
K1 nivolumab
K1 NSCLC
PB Elsevier science inc
SN 1556-0864
YR 2018
FD 2018-10-01
LK https://hdl.handle.net/10668/27248
UL https://hdl.handle.net/10668/27248
LA en
DS RISalud
RD Apr 10, 2025